SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Di&g Regulatory News (ADIG)

  • This share is currently suspended. It was suspended at a price of 13.33

Share Price Information for Abrdn Di&g (ADIG)

Share Price is delayed by 15 minutes
Get Live Data
13.33    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £40.16m
ADIG Live PriceLast checked at - London Stock Exchange

Intraday Abrdn Di&g Share Chart

Kepler Trust Intelligence: New Research

22 Mar 2023 07:00

RNS Number : 7632T
Aberdeen Diversified I&G Trust PLC
22 March 2023
 

Aberdeen Diversified Income & Growth: New Research

22/03/2023

ADIG's significant discount may present a good opportunity to access a diverse range of high-quality, good value investment opportunities…

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAKDFALFDEFA
Date   Source Headline
1st May 20269:44 amRNSUpdate on First Distribution
23rd Apr 20267:00 amRNSFirst distribution in Liquidation
30th Mar 20262:58 pmRNSResult of General Meeting
27th Mar 202611:21 amRNSReplace - Apportionment Ratio - Feb 2026 B shares
25th Mar 20266:00 pmRNSABRDN Diversified Income and Growth
18th Mar 20263:42 pmRNSApportionment Ratio for Feb 2026 B share issue
11th Mar 20267:02 amRNSCircular and Notice of General Meeting
11th Mar 20267:00 amRNSUpdate on Managed Wind-Down
5th Mar 20267:00 amRNSInterim Dividend
11th Feb 20267:00 amRNSB Share Scheme Distribution
5th Feb 20269:35 amRNSHolding(s) in Company
4th Feb 20267:00 amRNSUpdate on Managed Wind-Down
23rd Jan 20267:00 amRNSChange of Corporate Broker
19th Jan 202611:19 amRNSDoc re. Half Yearly Report
8th Jan 20261:59 pmRNSApportionment Ratio for Nov 2025 B share issue
8th Jan 202612:53 pmRNSMonth End Net Asset Value(s)
8th Jan 20267:00 amRNSManaged Wind-Down Update
6th Jan 202611:26 amRNSQuarterly disclosure
22nd Dec 20253:42 pmRNSMonth End Net Asset Value(s)
19th Dec 202512:00 pmRNSHalf-year Financial Report
19th Dec 202512:00 pmRNSHalf-year Financial Report
18th Dec 20253:00 pmRNSUpdate on Managed Wind Down
18th Dec 20253:00 pmRNSUpdate on Managed Wind Down
6th Nov 20251:47 pmRNSMonth End Net Asset Value(s)
29th Oct 20257:00 amRNSB Share Scheme Distribution
10th Oct 20257:00 amRNSMonth End Net Asset Value(s)
2nd Oct 20254:38 pmRNSQuarterly disclosure
1st Oct 202510:38 amRNSUpdate on Managed Wind-Down
30th Sep 202512:32 pmRNSNet Asset Value(s)
29th Sep 202512:34 pmRNSNet Asset Value(s)
26th Sep 202511:39 amRNSNet Asset Value(s)
25th Sep 202512:26 pmRNSNet Asset Value(s)
25th Sep 20259:30 amRNSInterim Dividend
24th Sep 202512:35 pmRNSNet Asset Value(s)
23rd Sep 202511:33 amRNSNet Asset Value(s)
22nd Sep 202512:17 pmRNSNet Asset Value(s)
19th Sep 202510:48 amRNSNet Asset Value(s)
18th Sep 20252:12 pmRNSHolding(s) in Company
18th Sep 202511:20 amRNSNet Asset Value(s)
17th Sep 202511:46 amRNSNet Asset Value(s)
16th Sep 202510:56 amRNSNet Asset Value(s)
15th Sep 202511:30 amRNSNet Asset Value(s)
12th Sep 202512:05 pmRNSNet Asset Value(s)
11th Sep 202511:44 amRNSNet Asset Value(s)
10th Sep 202511:40 amRNSNet Asset Value(s)
9th Sep 202510:53 amRNSNet Asset Value(s)
8th Sep 202512:04 pmRNSNet Asset Value(s)
5th Sep 202512:22 pmRNSNet Asset Value(s)
4th Sep 20252:59 pmRNSMonth End Net Asset Value(s)
4th Sep 202511:05 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.